

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.
You can purchase shares of BondBloxx BB-Rated USD High Yield Corporate Bond ETF (ARCA:XBB) through any online brokerage.
There are no as such competitors for BondBloxx BB-Rated USD High Yield Corporate Bond ETF.
There is no analysis for BondBloxx BB-Rated USD High Yield Corporate Bond ETF to provide a consensus price target.
The stock price for BondBloxx BB-Rated USD High Yield Corporate Bond ETF (ARCA: XBB) is $39.8451 last updated November 11, 2026 at 8:00 PM EST.
There are no upcoming dividends for BondBloxx BB-Rated USD High Yield Corporate Bond ETF.
BondBloxx BB-Rated USD High Yield Corporate Bond ETF does not have any upcoming earnings scheduled.
There is no upcoming split for BondBloxx BB-Rated USD High Yield Corporate Bond ETF.
The Fund is newly organized, non-diversified and seeks to track the investment results of the ICE BofA BB US Cash Pay High Yield Constrained Index (the Index), which contains all bonds in the ICE BofA US Cash Pay High Yield Index (the Underlying...